Samples from test batches of the Covid-19 vaccine made by Siam Bioscience have passed quality testing at AstraZeneca’s designated laboratories in Europe and the United States, the company announced on Sunday.
In a press release — in English but with numerous grammatical errors — James Teague, Country President, AstraZeneca (Thailand) Ltd said:
“We have seen a series of significant and promising progress [sic] in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks. First, the Thai Food and Drug Administration approved Siam Bioscience as a manufacturing facility for COVID-19 vaccine AstraZeneca. Last week, the samples of COVID-19 vaccine AstraZeneca…
